More interval breast cancers detected when screening mammography recall rates are low.
Lower screening mammography recall rates are associated with higher rates of interval cancers, according to a study published in the journal Radiology.
Researchers from the United States and the United Kingdom sought to determine the relationship between recall levels following screening mammography and interval cancers among women aged 50 to 70 years. Data were drawn from a 36-month period with a three-year follow-up.
The researchers retrospectively analyzed 5,126,689 screening episodes and found an average recall to assessment rate (RAR) of 4.56 percent (1.64 percent-8.42 percent), cancer detection rate of 8.1 per 1,000 women screened and interval cancer rate (ICR) of 3.1 per 1,000 women screened.
Overall, a significant negative association was found between RAR and ICR, with approximately one fewer interval cancer for every additional 80 to 84 recalls. Women aged 50 to 54 years, 60 to 64 years, and 65 to 69 years had similar negative correlations, incident screens, and prevalent screens. However, no significant relationship was found among women aged 55 to 59 years.
“Recall rate had more of an impact on interval cancer in patients who are older,” Elizabeth S. Burnside, MD, MPH, from the University of Wisconsin School of Medicine and Public Health in Madison, Wisc., said in a release. “The lower number of recalls required per interval cancer avoided in older women and incident screens as compared to younger women and prevalent screens, respectively, demonstrates a slightly different ‘value’ in terms of the trade-off between recall rate and interval cancers.”
The researchers noted that additional research will help determine a specific minimum threshold for recall rate and assess the impact of digital mammography on the relationship between recall rate and interval cancers.
“A big-picture lesson in our study is the power of rigorous quality assurance infrastructure to help breast cancer screening programs learn from actual practice and use that information to make informed programmatic decisions for the future,” Burnside added. “This study documents the benefit of carefully tracking mammography use and outcomes as achieved in the [U.K. National Health Service Breast Screening Program].”
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.